Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | CA5A | P35218 | 1/20 | 0.32 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.32 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.32 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.32 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.32 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.32 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.32 |
| ▸ | PIP4K2A | P48426 | 1/20 | 0.31 |
| ▸ | LOX | P28300 | 1/20 | 0.30 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.30 |
| ▸ | KDR | P35968 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2702752 | 0.80 | ALOX15 (0.33) | ALOX15PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL1548616 | 0.78 | CA2 (0.39) | CA1CA2CA4CA5ACA5B | |
| SCHEMBL3439198 | 0.76 | NOS1 (0.43) | CA1CA2CA4CA5ACA5B | |
| SCHEMBL2885927 | 0.74 | FBP1 (0.35) | CA1CA2CA4CA5ACA5B | |
| SCHEMBL7993752 | 0.74 | LOXL2 (0.34) | CA1CA2CA4CA5ACA5B | |
| SCHEMBL24667434 | 0.69 | HCAR2 (0.55) | KMT2A | |
| SCHEMBL4171168 | 0.69 | CA1 (0.30) | CA1CA2CA4CA5ACA5B | |
| SCHEMBL3123975 | 0.69 | LOXL2 (0.50) | LOXLOXL2 | |
| SCHEMBL9826897 | 0.69 | MEN1 (0.37) | KMT2APIP4K2ALOXLOXL2KDR | |
| SCHEMBL18827776 | 0.69 | LOXL2 (0.32) | PSEN1PSEN2APH1BNCSTNAPH1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200060276-A1 | THIAZOLE COMPOUND AND HERBICIDE | OAT AGRIO CO., LTD. (JP) | 2020-02-27 | — | — | US | disclosed |
| US-20200060276-A1 | THIAZOLE COMPOUND AND HERBICIDE | OAT AGRIO CO., LTD. (JP) | 2020-02-27 | — | — | US | disclosed |
| US-20090048112-A1 | Novel Herbicides | SYNGENTA LIMITED (GB) | 2009-02-19 | — | — | US | disclosed |
| US-20090048112-A1 | Novel Herbicides | SYNGENTA LIMITED (GB) | 2009-02-19 | — | — | US | disclosed |
| US-20090048112-A1 | Novel Herbicides | SYNGENTA LIMITED (GB) | 2009-02-19 | — | — | US | disclosed |
| EP-1885720-A2 | 4-(THIAZOL-2-YLTHIOALKYL)-PYRAZOLES AND THEIR USE AS HERBICIDES | Syngenta Limited (GB) | 2008-02-13 | — | — | EP | disclosed |
| WO-2006123088-A2 | 4- (THIAZOL-2-YLTHIOALKYL) -PYRAZOLES AND THEIR USE AS HERBICIDES | SYNGENTA LIMITED (GB) | 2006-11-23 | — | — | WO | disclosed |
| EP-0075840-B1 | HETEROCYCLIC PHENYL ETHERS, PROCESS FOR THEIR PREPARATION AND HERBICIDES CONTAINING THEM | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-11-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200060276-A1 | THIAZOLE COMPOUND AND HERBICIDE | OR10J3, OXSR1, OXER1 | CA1 1575/4885CA2 631/4885CA4 327/4885 |
| US-20090048112-A1 | Novel Herbicides | HAX1, MTX1, CYP4X1 | CA1 1084/4885CA2 668/4885CA4 1338/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.